Most cells that have been tested have two trans plasma membrane electron transport systems for the oxidation of cytosolic NADH. The first is an oxidase which transfers electrons from NADH to oxygen through dehydrogenases to coenzyme Q and a terminal reduced coenzyme Q oxidase. The second system for trans membrane electrontransport from NADH is a protein complex called porin or Voltage Dependent Anion Channel (VDAC). It transfers electrons across the membrane on a pair of SH groups which line the channel. It does not react directly with oxygen but transfers electrons to an external artificial acceptor such as ferricyanide. The natural acceptor is most likely to be semidehydroascorbic acid which would be reduced to ascorbate which can be oxidized by ascorbate oxidase acting as the terminal oxidase. Activation of NADH oxidation in serum deficient media stimulates growth of cultured cells. Which oxidase contributes to the growth stimulation has not been determined. Here we consider inhibitors which can help define which NADH oxidation controls growth Growth stimulation is much greater with transformed tumor cells than with untransformed cells. Inhibitors of transmembrane electron transport inhibit growth and a wide group of well known anti tumor drugs are excellent inhibitors of the transmembrane electron transport in tumor cells and are less inhibitory in untransformed cells. The terminal oxidase copper protein, referred to as tNOX or ECTO-NOX, appears to be modified with cell transformation so that it is less firmly attached to the outer surface of the cell and is released into the sera more than c NOX.1 Activation of the trans membrane electron transport increases the NAD+ concentration inside the cell by oxidation of NADH. Since the reduction of pyruvate , which also increases cytosolic NAD, can stimulate growth a function of NAD in growth control is indicated which could involve activation of sirtuin 1 by NAD in the cytoplasm. Sirtuin 1 is known to control the cell cycle and apoptosis.
Introduction
The search for an NADH oxidase in the plasma membrane started with the observation that adenylyl cyclase was inhibited by increasing NADH in fat cells [1] . Since the cyclase is in inner layer of the plasma membrane it was considered that the NADH could act at the plasma membrane and might involve an NADH dehydrogenase or oxidase. Assay of liver and fat cell plasma membrane indicated a slow rate of NADH oxidation and NADH dehydrogenase activity [2, 3] .Since the plasma membrane NADH oxidase was not inhibited by cyanide and other inhibitors ,of mitochondrial NADH oxidase the activity was not based on mitochondrial contamination [4] . Elimination of contamination by other endomembranes was later based on assay of impermeable electron acceptors by isolated intact cells or perfused tissue [5, 6] . Review of the literature showed that reduction of impermeable dyes by cells had been observed as early as 1925 [7] and in 1929 F.G.Barron emphasized that impermeable dye reduction was based on transmembrane electron transport [8] . In 1947 Brooks [9] reported stimulation of cell division in sea urchin eggs by impermeable oxidants but there seems to have been no further development of that growth effect until Ellem and Kay described ferricyanide stimulation of growth with serum starved melanoma cells in 1983 [10] . Previous to Ellem and Kays study ferricyanide and other impermeable oxidants,such as indophenols,had been used as electron acceptors for NADH oxidation by isolated plasma membrane [11, 12] . Stimulation or inhibition by hormones or growth factors indicated that the NADH oxidase could be the NADH sensor we were looking for [13] . The development of procedures for preparation of purified plasma membranes in D.J.Morre's laboratory was essential for the measurement of the NADH oxidase in isolated plasma membrane [14] . The transmembrane orientation of the electron transport was established by measuring the reduction of ferricyanide by isolated rat liver cells and in perfused liver [5, 6] . With isolated liver cells it was possible to show evidence for a transmembrane oxidase activity by measuring the amount of cyanide insensitive oxidase that was inhibited by adding ferricyanide to the cells. Cyanide inhibited 85% of oxygen uptake and ferricyanide inhibited half of the cyanide insensitive activity [15] .
The ferricyanide has been shown to take electrons from a second trans membrane electron carrier VDAC [16] so the component of oxygen uptake inhibited by ferricyaide could be based on VDAC.The remaining 8 % of oxygen uptake could be from the E-NOX NADH oxidase. Perfused rat heart also had hormone controlled ferricyanide reduction Assay of perfusate alone showed no ferricyanide reduction which indicated fhat the reduction of ferricyanide was not based on excretion of reducing agents. VDAC may be involved in trans mrmbrane electron transport but its contribution to growth control has not been examined [17] . In order to establish the source of electrons assay of oxidation of cellular NADH was necessary. Incubation of cells with ferricyanide or diferric transferrin to increase the transmembrane electron transport caused increased oxidation of internal NADH [18] .
THE OXIDASE COMPLEX The current evidence indicates that main components of the oxidase are a pair of NADHCoenzyme Q reductases on the cytosolic side of the plasma membrane [19] and a reduced coenzyme Q oxidase on the outside of the membrane so that coenzyme Q would transfer electrons across the lipid bilayer [20] . Two well known NADH dehrdrogenases, NADH cytochrome b5 reductase [21] and RO-1 NADH/NADPH dehydrogenase [22] (DT Diaphorase) can act as NADH -CoQreductases and are found in the plasma membrane. A unique polyfunctional protein on the outside of the plasma membrane is a reduced coenzyme Q oxidase which can finish carrying electrons across the membrane to oxygen to form water [23] . In early study of plasma membrane NADH oxidase the extraction of a protein with NADH oxidase activity, referred to as NOX appeared to be the wanted enzyme. However it did not require coenzyme Q which was required by the oxidase in the membrane [24] . The discovery by Kishi et al [25] that the NOX enzyme was a reduced coenzyme Q oxidase was more consistent with function in a multi component oxidase.as the terminal oxidase. The significance of the endogenous NADH oxidase activity in the isolated NOX is not clear since there is little NADH on the outside of the cell. Further study of NOX revealed other catalytic activity. It has thiolgroups which have protein dithiolisomerase activity. This PDI activity would be available to proteins outside the cell and may act in unfolding of external proteins for uptake [26] NOX also shows oscillation of its NADH oxidase activity with a peak to peak time of 24 min [20] .
THE FUNCTION OF NOX When NOX was purified as a protein with NADH oxidase activity it was confusing because it had different properties than the NADH oxidase in the membrane.An alternate electron carrier in the plasma membrane is coenzyme Q. It was shown to be required by solvent extraction and restoration of activity by added coenzyme Q [24] . Analogs of coenzyme Q such as capsciasin,chloroquine and pericidin inhibited NADH oxidase in the membrane and the inhibition was reversed by added coenzyme Q. When Kishi et al [25] showed that the NOX protein was a reduced Coenzyme Q oxidase it changed the whole role for the NOX protein to that of a terminal oxidase for the trans membrane oxidase.
IDENTIFICATION OF VDAC
During the purification 0f NOX it was observed that NADH ferricyanidereductase separated from the NOX oxidase [20] . Later the purification of the ferricyanidereductase was taken up by Lawens Group [16] and when purified it was recognized as VDAC which is a membrane spanning polymer with SH groups on the walls of an interior channel [27] . It is rather selective in reacting with electron acceptors since it reduces ferricyanide or coenzyme Q but not indophenol which is the acceptor most often used with NADH dehydrogenases [28] . Of course the electron transport to ferricyanide through VDAC is artificial and until the natural carrier is identified the activity should be considered as an artifact. The role of VDAC may be a redox controlled channel with control based on NADH concentration.A relation between VDAC and apoptosis has been proposed [29, 30] .
ANTI TUMOR DRUGS Inhibition of the plasma membrane oxidase by anti tumor drugs developed as a result of Karl Folkers interest in a possible role for coenzyme Q in treatment of cancer [31] . Folkers suggested to Crane,that adriamycin should be tested for inhibition of mitochondrial oxidases. Adriamycin did inhibit NADH oxidase in mitochondria but assay of NADH oxidase in plasma membrane was done at the same time and we found that lower concentration of adriamycin was a very effective inhibitor of the plasma membrane oxidase [32] . Actinomycin D and cisdiaminedichloro platinum 11 also were found to inhibit plasma membrane electron transport,while the trans diamine di chloro platinum,which is inactive against tumors, did not inhibit [33, 34, 35] . We arranged to test some temperature sensitive transformed and untransformed cells developed by Dr. Janice Chou at NIH. The transformed cells were more sensitive to the anti tumor drugs [35] . A comparison of plasma membrane redox activity shows that transformed cells usually have a lower rate of ferricyanide reduction, which may indicate less activity of the VDAC dehydrogenase (Table 1) . There is one exception with higher rates in transformed cells [36] .
TESTING FOR VDAC Since VDAC depends on SH groups for electron transfer it is very succeptable to inhibition by mercurials or lead [27, 37] (Table 2) . Erythrocyte Plasma membrane from various sources have no oxidase activity but do have good NADH ferricyanidereductaseactivity.Since the reductase activity is completely inhibited by low concentration of mercurials such as PCMB or PCMBS it indicates that erythrocyte membranes have only VDAC for trans plasma membrane NADH oxidation [41] . However Evidence for coenzyme Q function in erythrocyte membrane ferricyanide reduction complicates the interpretion and suggests that part of the oxidase system may remain in the erythrocyte membranes [42] or that VDAC requires coenzyme Q for electron transport. Since the erythrocytes do not grow they do not provide a test of the VDAC system as a growth stimulator. With other cells low levels of mercurialsgive only partial inhibition of ferricyanide reduction with more inhibition at higher concentrations indicating more protected sites. This indicates that not all ferricyanide reduction is based on VDAC (Table 2) . For example HeLa cell ferricyanide reduction (750 nm/minxmgww) is partially inhibited (400) by coQ analog Piericidin A or ethoxycoQ (520) and restored by coQ (780) indicating that part of the ferricyanide reduction can be based on the oxidase or that part of ferricyanide reduction by VDAC requires coenzyme Q. Extraction of liver and erythrocyte plasma membranes also shows a requirement for coenzyme Q for ferricyanide reduction (Table 3) . It remains to be seen if extraction of purified VDAC would show a Q requirement for ferricyanide reductase. A function of coenzyme Q bound to VDAC would be analogous to the function of Q bound to the uncoupling protein of mitochondria [44] . Extraction also decreases NADH oxidase of liver plasma membrane and activity is partly restored with coenzyme Q. (Table 4) The very specific inhibition of NADH ferricyanide reduction by low concentration of Zinc ions may also provide a test for VDAC activity [38] .
TESTING FOR OXIDASE Since VDAC appears to have no NADH Oxidase activity testing membranes for oxidase is straightforward. With rat liver membrane The NADH oxidase is slow and is slightly stimulated by coenzyme Q. After heptane extraction of coenzyme Q 84 % of the activity is lost And 80% of the oxidase is restored with coenzyme Q addition. When the oxidase is activated with diferric transferrin activity increases 25% And extraction of coenzyme Q inhibits 80%. Readdition of Coenzyme Q restores 80% [44] . Since diferric transferrin also stimulates proliferation of cells a function of the oxidase in growth is indicated (Table 4) .
In an extensive study of capsaicin inhibition of growth and oxidase in transformed and untransformed cells,Morre et al show that capsaicin, a competitive inhibitor of coenzyme Q function [39] , strongly inhibits oxidase and growth of transformed cells but has little effect on untransformed cells. This suggests that the oxidase is required for growth in transformed cells. However extraction of coenzyme Q from untransformed rat liver plasma membrane shows a loss of oxidase activity, which is 80%, restored by addition of coenzyme Q (Table 4) . Coenzyme Q stimulates growth of HeLa cells in serum free media 100%, and ferricyanide stimulates an additional 50%, which implies that two systems are stimulating growth (Sun PNAS) [ 24] . It appears that coenzyme Q requirement cannot be used to distinguish the two redox systems. Further indicated by coenzyme Q extraction and restoration of ferricyanide reduction with erythrocyte membrane where there is no oxidase (Table 3) . A role for the oxidase in cell growth is supported by growth stimulation by electron acceptors which do not accept electrons from VDAC such as indophenols but these stimulations tend to be less than with ferricyanjde which indicates that ferricyanide may accept electrons from both the oxidase and VDAC (Table 5) SYNAPTIC MEMBRANES The redox enzyme activity in synaptic plasma membranes is more complicated than in tissue cells. Up to five NADH dehydrogenase bands have been seen in electrophoresis. Several of these react to antibodies to mitochondrial VDACs 1,2 and 3 [40] . Assay of synaptic plasma membranes for ferricyanide and indophenols reductase show effects of neurotransmitters on the activity.since the effects on ferricyanide and indophenols reductase are different the presence of both oxidase and dehydrogenase is indicated.
C0NCLUSIONS
There are two electron transport systems in the plasma membrane which can oxidize cytosolic NADH. One is a NADH oxidase which uses oxygen as electron acceptor [41] . Since the coenzyme Q oxidase is located on the outside of the cell it is now called ECTO-NOX ( 48)The second is a trans membrane voltage dependent anion channel (VDAC), which transfers electrons across the membrane on SH groups [29] . It does not appear to react with oxygen but uses selected impermeable electron accepters on the outside of the membrane such as ferricyanide.One natural accepter is coenzyme Q which is not impermeable so it does not define any role.considering what else is available as acceptor and the reduction of Conzyme Q may be part of its role as an electron carrier in VDAC. The most likely acceptor is semidehydroascorbate. Since ascorbic acid is available in sera along with ascorbate oxidase, which produces the semi reduced form. When it oxidizes the reduced form the ascorbate oxidase, would be acting as the terminal oxidase for the VDAC system. Since the final product of both the oxidase and the VDAC systems is NAD+, they can both contribute to the activation of sirtuin 1 in the cytosol which can activate transcription factors for growth [47] . This would best fit the additive growth effect of coenzyme Q and ferricyanide. On the other hand the role of VDAC as a porin may be connected to nutrient uptake for growth which could be controlled by the VDAC coenzyme Q redox state. Since antibody inhibition of VDAC has been observed in autistic patients better understanding the redox function in the plasma membrane may give new approaches to autism [46] . Selected data from Reference 33 T transformed, N normal 
